Yuhao Dong1,2, Qianjin Feng3, Wei Yang3, Zixiao Lu3, Chunyan Deng3, Lu Zhang1, Zhouyang Lian1, Jing Liu1, Xiaoning Luo1, Shufang Pei1, Xiaokai Mo1,2, Wenhui Huang1, Changhong Liang1, Bin Zhang1, Shuixing Zhang4. 1. Department of Radiology, Guangdong General Hospital/Guangdong Academy of Medical Sciences, No. 106 Zhongshan Er Road, 510080, Guangzhou, Guangdong Province, People's Republic of China. 2. Graduate College, Shantou University Medical College, Shantou, Guangdong, People's Republic of China. 3. The Guangdong Provincial Key Laboratory of Medical Image Processing, School of Biomedical Engineering, Southern Medical University, Guangzhou, Guangdong, People's Republic of China. 4. Department of Radiology, Guangdong General Hospital/Guangdong Academy of Medical Sciences, No. 106 Zhongshan Er Road, 510080, Guangzhou, Guangdong Province, People's Republic of China. shui7515@126.com.
Abstract
OBJECTIVES: To predict sentinel lymph node (SLN) metastasis in breast cancer patients using radiomics based on T2-weighted fat suppression (T2-FS) and diffusion-weighted MRI (DWI). METHODS: We enrolled 146 patients with histologically proven breast cancer. All underwent pretreatment T2-FS and DWI MRI scan. In all, 10,962 texture and four non-texture features were extracted for each patient. The 0.623 + bootstrap method and the area under the curve (AUC) were used to select the features. We constructed ten logistic regression models (orders of 1-10) based on different combination of image features using stepwise forward method. RESULTS: For T2-FS, model 10 with ten features yielded the highest AUC of 0.847 in the training set and 0.770 in the validation set. For DWI, model 8 with eight features reached the highest AUC of 0.847 in the training set and 0.787 in the validation set. For joint T2-FS and DWI, model 10 with ten features yielded an AUC of 0.863 in the training set and 0.805 in the validation set. CONCLUSIONS: Full utilisation of breast cancer-specific textural features extracted from anatomical and functional MRI images improves the performance of radiomics in predicting SLN metastasis, providing a non-invasive approach in clinical practice. KEY POINTS: • SLN biopsy to access breast cancer metastasis has multiple complications. • Radiomics uses features extracted from medical images to characterise intratumour heterogeneity. • We combined T 2 -FS and DWI textural features to predict SLN metastasis non-invasively.
OBJECTIVES: To predict sentinel lymph node (SLN) metastasis in breast cancerpatients using radiomics based on T2-weighted fat suppression (T2-FS) and diffusion-weighted MRI (DWI). METHODS: We enrolled 146 patients with histologically proven breast cancer. All underwent pretreatment T2-FS and DWI MRI scan. In all, 10,962 texture and four non-texture features were extracted for each patient. The 0.623 + bootstrap method and the area under the curve (AUC) were used to select the features. We constructed ten logistic regression models (orders of 1-10) based on different combination of image features using stepwise forward method. RESULTS: For T2-FS, model 10 with ten features yielded the highest AUC of 0.847 in the training set and 0.770 in the validation set. For DWI, model 8 with eight features reached the highest AUC of 0.847 in the training set and 0.787 in the validation set. For joint T2-FS and DWI, model 10 with ten features yielded an AUC of 0.863 in the training set and 0.805 in the validation set. CONCLUSIONS: Full utilisation of breast cancer-specific textural features extracted from anatomical and functional MRI images improves the performance of radiomics in predicting SLN metastasis, providing a non-invasive approach in clinical practice. KEY POINTS: • SLN biopsy to access breast cancer metastasis has multiple complications. • Radiomics uses features extracted from medical images to characterise intratumour heterogeneity. • We combined T 2 -FS and DWI textural features to predict SLN metastasis non-invasively.
Authors: Liling Zhu; Liang Jin; Shunrong Li; Kai Chen; Weijuan Jia; Quanyuan Shan; Stephen Walter; Erwei Song; Fengxi Su Journal: Breast Cancer Res Treat Date: 2013-01-05 Impact factor: 4.872
Authors: Philipp Kickingereder; Michael Götz; John Muschelli; Antje Wick; Ulf Neuberger; Russell T Shinohara; Martin Sill; Martha Nowosielski; Heinz-Peter Schlemmer; Alexander Radbruch; Wolfgang Wick; Martin Bendszus; Klaus H Maier-Hein; David Bonekamp Journal: Clin Cancer Res Date: 2016-10-10 Impact factor: 12.531
Authors: Anthony Lucci; Linda Mackie McCall; Peter D Beitsch; Patrick W Whitworth; Douglas S Reintgen; Peter W Blumencranz; A Marilyn Leitch; Sukumal Saha; Kelly K Hunt; Armando E Giuliano Journal: J Clin Oncol Date: 2007-05-07 Impact factor: 44.544
Authors: Ke Nie; Liming Shi; Qin Chen; Xi Hu; Salma K Jabbour; Ning Yue; Tianye Niu; Xiaonan Sun Journal: Clin Cancer Res Date: 2016-05-16 Impact factor: 12.531
Authors: John A Olson; Linda M McCall; Peter Beitsch; Pat W Whitworth; Douglas S Reintgen; Peter W Blumencranz; A Marilyn Leitch; Sukamal Saha; Kelly K Hunt; Armando E Giuliano Journal: J Clin Oncol Date: 2008-07-20 Impact factor: 44.544
Authors: Ji Eun Park; Donghyun Kim; Ho Sung Kim; Seo Young Park; Jung Youn Kim; Se Jin Cho; Jae Ho Shin; Jeong Hoon Kim Journal: Eur Radiol Date: 2019-07-26 Impact factor: 5.315
Authors: K Deike-Hofmann; T Kuder; F König; D Paech; C Dreher; S Delorme; H-P Schlemmer; S Bickelhaupt Journal: Radiologe Date: 2018-11 Impact factor: 0.635
Authors: William Rogers; Sithin Thulasi Seetha; Turkey A G Refaee; Relinde I Y Lieverse; Renée W Y Granzier; Abdalla Ibrahim; Simon A Keek; Sebastian Sanduleanu; Sergey P Primakov; Manon P L Beuque; Damiënne Marcus; Alexander M A van der Wiel; Fadila Zerka; Cary J G Oberije; Janita E van Timmeren; Henry C Woodruff; Philippe Lambin Journal: Br J Radiol Date: 2020-02-26 Impact factor: 3.039
Authors: Yan Yan Yu; Rui Zhang; Rui Tong Dong; Qi Yun Hu; Tao Yu; Fan Liu; Ya Hong Luo; Yue Dong Journal: Br J Radiol Date: 2019-04-01 Impact factor: 3.039